Bajaj Healthcare Limited has informed the Exchange regarding a press release dated September 13, 2023, titled "Receipt of the Establishment Inspection Report (EIR) from the United State Food and Drug Administration (USFDA), for the Pre-approval inspection that was carried out by the USFDA in November, 2022".